Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum, BMC Medical Genetics

Por um escritor misterioso
Last updated 24 outubro 2024
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Background Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder characterized by broad thumbs and halluces. RSTS is caused by mutations in CREBBP and in EP300 genes in 50–60% and 8%, respectively. Up to now, 76 RSTS-EP300 patients have been described. We present the clinical and molecular characterization of a cohort of RSTS patients carrying EP300 mutations. Methods Patients were selected from a cohort of 72 individuals suspected of RSTS after being negative in CREBBP study. MLPA and panel-based NGS EP300 were performed. Results Eight patients were found to carry EP300 mutations. Phenotypic characteristics included: intellectual disability (generally mild), postnatal growth retardation, infant feeding problems, psychomotor and language delay and typical facial dysmorphisms (microcephaly, downslanting palpebral fissures, columella below the alae nasi, and prominent nose). Broad thumbs and/or halluces were common, but angulated thumbs were only found in two patients. We identified across the gene novel mutations, including large deletion, frameshift mutations, nonsense, missense and splicing alterations, confirming de novo origin in all but one (the mother, possibly underdiagnosed, has short and broad thumbs and had learning difficulties). Conclusions The clinical evaluation of our patients corroborates that clinical features in EP300 are less marked than in CREBBP patients although it is difficult to establish a genotype-phenotype correlation although. It is remarkable that these findings are observed in a RSTS-diagnosed cohort; some patients harbouring EP300 mutations could present a different phenotype. Broadening the knowledge about EP300-RSTS phenotype may contribute to improve the management of patients and the counselling to the families.
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Genes, Free Full-Text
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Rubinstein–Taybi syndrome: clinical and molecular overview, Expert Reviews in Molecular Medicine
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Rubinstein–Taybi syndrome - Wikipedia
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Frontiers Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Genes, Free Full-Text
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Genes, Free Full-Text
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome. - Abstract - Europe PMC
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Genes, Free Full-Text
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Sanger sequencing confirmation. A de novo in-frame deletion variant
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein -Taybi syndrome detected by aCGH. - Abstract - Europe PMC
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Images showing classical RSTS features of patient including thickened
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Frontiers Genetic Diagnosis of Rubinstein–Taybi Syndrome With Multiplex Ligation-Dependent Probe Amplification (MLPA) and Whole-Exome Sequencing (WES): Case Series With a Novel CREBBP Variant
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
PDF) Genetic heterogeneity in Rubinstein-Taybi syndrome: Delineation of the phenotype of the first patients carrying mutations in EP300
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease - ScienceDirect

© 2014-2024 chuaphuocthanh.kiengiang.vn. All rights reserved.